Peter K. Miller
Pharmaceutical Sciences
R and D meat
Norway
Biography
Peter Miller joined the Board of Directors of OptiNose AS in 2008 when he first became familiar with the Company’s unique approach to nasal drug delivery and convinced of the potential for using it to create clinically important new products. In 2010, in partnership with Ramy Mahmoud, Mr. Miller led the start-up of Optinose in collaboration with Avista Capital Partners, acquiring OptiNose AS and accepting the role of CEO. He also serves as a member of the Board of Directors of Optinose.
Research Interest
Medical
